{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:24:09Z","timestamp":1792034649494,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijid.2025.107877","type":"journal-article","created":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T12:20:33Z","timestamp":1741522833000},"page":"107877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Host-directed therapy in diabetes and tuberculosis comorbidity toward global tuberculosis elimination"],"prefix":"10.1016","volume":"155","author":[{"given":"Steven G.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Bowness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5653-1818","authenticated-orcid":false,"given":"Jacqueline M.","family":"Cliff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.107877_bib0001","series-title":"Global tuberculosis report","year":"2024"},{"key":"10.1016\/j.ijid.2025.107877_bib0002","series-title":"IDF diabetes atlas","year":"2021"},{"key":"10.1016\/j.ijid.2025.107877_bib0003","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2025.107877_bib0004","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5588\/ijtld.22.0685","article-title":"Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes","volume":"27","author":"Goletti","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2025.107877_bib0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1741-7015-9-81","article-title":"The impact of diabetes on tuberculosis treatment outcomes: a systematic review","volume":"9","author":"Baker","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.ijid.2025.107877_bib0006","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5588\/ijtld.23.0507","article-title":"A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs","volume":"28","author":"Cevik","year":"2024","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2025.107877_bib0007","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.therap.2022.05.005","article-title":"Impact of diabetes mellitus on rifampicin's plasma concentration and bioavailability in patients with tuberculosis: a systematic review and meta-analysis study","volume":"78","author":"El-Sheikh","year":"2023","journal-title":"Therapie"},{"key":"10.1016\/j.ijid.2025.107877_bib0008","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4239\/wjd.v15.i5.853","article-title":"Tuberculosis-diabetes comorbidities: mechanistic insights for clinical considerations and treatment challenges","volume":"15","author":"MAA","year":"2024","journal-title":"World J Diabetes"},{"key":"10.1016\/j.ijid.2025.107877_bib0009","article-title":"The association between type 2 diabetes and pulmonary cavitation revealed among IGRA-positive tuberculosis patients","volume":"10","author":"Yang","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ijid.2025.107877_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292397","article-title":"Interactive effect of oral anti-hyperglycaemic or anti-hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis","volume":"18","author":"Trivedi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.107877_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1244450","article-title":"The impact of diabetes mellitus on the emergence of multi-drug resistant tuberculosis and treatment failure in TB-diabetes comorbid patients: a systematic review and meta-analysis","volume":"11","author":"Rehman","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijid.2025.107877_bib0012","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tube.2017.01.006","article-title":"The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes","volume":"103","author":"Perez-Navarro","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.ijid.2025.107877_bib0013","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13643-018-0828-0","article-title":"Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis","volume":"7","author":"Tegegne","year":"2018","journal-title":"Syst Rev"},{"key":"10.1016\/j.ijid.2025.107877_bib0014","first-page":"1310","article-title":"Therapeutic strategies for tuberculosis: progress and lessons learned","volume":"37","author":"Sun","year":"2024","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/j.ijid.2025.107877_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101672","article-title":"Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies","volume":"65","author":"Tiwari","year":"2023","journal-title":"Semin Immunol"},{"key":"10.1016\/j.ijid.2025.107877_bib0016","article-title":"Tuberculosis and diabetes mellitus: relating immune impact of co-morbidity with challenges in disease management in high burden countries","volume":"29","author":"Abbas","year":"2022","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.ijid.2025.107877_bib0017","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.chest.2017.02.032","article-title":"Defining a research agenda to address the converging epidemics of tuberculosis and diabetes: Part 2: underlying biologic mechanisms","volume":"152","author":"Ronacher","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2025.107877_bib0018","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/infdis\/jiv568","article-title":"Transient hyperglycemia in patients with tuberculosis in Tanzania: implications for diabetes screening algorithms","volume":"213","author":"Boillat-Blanco","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2025.107877_bib0019","doi-asserted-by":"crossref","first-page":"e1375","DOI":"10.1002\/ctm2.1375","article-title":"Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity","volume":"13","author":"Eckold","year":"2023","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.ijid.2025.107877_bib0020","article-title":"The definition of tuberculosis infection based on the spectrum of tuberculosis disease","volume":"17","author":"Migliori","year":"2021","journal-title":"Breathe (Sheff)"},{"key":"10.1016\/j.ijid.2025.107877_bib0021","series-title":"WHO operational handbook on tuberculosis","year":"2023"},{"key":"10.1016\/j.ijid.2025.107877_bib0022","unstructured":"Kleynhans L, Kunsevi-Kilola C, Tshivhula H, Webber T, Keyser A, Prins N, et al. Human alveolar macrophage function is impaired in tuberculosis contacts with diabetes. Research Square. 27 November 2024. https:\/\/www.researchsquare.com\/article\/rs-5489046 . Accessed 22 March 2025."},{"key":"10.1016\/j.ijid.2025.107877_bib0023","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/eji.201545973","article-title":"Coincident diabetes mellitus modulates Th1-, Th2-, and Th17-cell responses in latent tuberculosis in an IL-10- and TGF-beta-dependent manner","volume":"46","author":"Kumar","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ijid.2025.107877_bib0024","doi-asserted-by":"crossref","first-page":"e13134","DOI":"10.1111\/sji.13134","article-title":"Latent M. tuberculosis infection is associated with increased inflammatory cytokine and decreased suppressor of cytokine signalling (SOCS)-3 in the diabetic host","volume":"95","author":"Masood","year":"2022","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.ijid.2025.107877_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2422790","article-title":"High dimensionality reduction and immune phenotyping of natural killer and invariant natural killer cells in latent tuberculosis-diabetes comorbidity","volume":"2022","author":"Kathamuthu","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ijid.2025.107877_bib0026","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/infdis\/jit241","article-title":"Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus","volume":"208","author":"Kumar","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2025.107877_bib0027","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/imm.12421","article-title":"Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis","volume":"144","author":"Kumar","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.ijid.2025.107877_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112108","article-title":"Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis","volume":"9","author":"Kumar","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.107877_bib0029","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2025.107877_bib0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/cid\/ciaa751","article-title":"Impact of intermediate hyperglycemia and diabetes on immune dysfunction in tuberculosis","volume":"72","author":"Eckold","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.107877_bib0031","doi-asserted-by":"crossref","first-page":"e46477","DOI":"10.7554\/eLife.46477","article-title":"Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity","volume":"8","author":"Kumar","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.ijid.2025.107877_bib0032","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/s41598-017-01767-4","article-title":"Systems immunology of diabetes-tuberculosis comorbidity reveals signatures of disease complications","volume":"7","author":"Prada-Medina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2025.107877_bib0033","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJMoa040573","article-title":"Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults","volume":"351","author":"Thwaites","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2025.107877_bib0034","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(12)70321-3","article-title":"Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis","volume":"13","author":"Critchley","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.107877_bib0035","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/17476348.2018.1515628","article-title":"Corticosteroids as an adjunct to tuberculosis therapy","volume":"12","author":"Schutz","year":"2018","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.ijid.2025.107877_bib0036","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s13063-024-08119-4","article-title":"Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trial","volume":"25","author":"Namale","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.ijid.2025.107877_bib0037","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.chom.2018.08.001","article-title":"Alveolar macrophages provide an early Mycobacterium tuberculosis Niche and initiate dissemination","volume":"24","author":"Cohen","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijid.2025.107877_bib0038","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1054\/tuld.1999.0215","article-title":"Increased TNF-alpha, IL-1 beta and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis","volume":"79","author":"Tsao","year":"1999","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.ijid.2025.107877_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005972","article-title":"NK-CD11c+ cell crosstalk in diabetes enhances IL-6-mediated inflammation during Mycobacterium tuberculosis infection","volume":"12","author":"Cheekatla","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2025.107877_bib0040","doi-asserted-by":"crossref","first-page":"e61333","DOI":"10.1371\/journal.pone.0061333","article-title":"Induced sputum MMP-1,-3 & -8 concentrations during treatment of tuberculosis","volume":"8","author":"Ugarte-Gil","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.107877_bib0041","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.4432","article-title":"Mycobacterium tuberculosis dysregulates MMP\/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation","volume":"235","author":"K\u00fcbler","year":"2015","journal-title":"J Pathol"},{"key":"10.1016\/j.ijid.2025.107877_bib0042","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141895","article-title":"Doxycycline host-directed therapy in human pulmonary tuberculosis","volume":"131","author":"Miow","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijid.2025.107877_bib0043","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s12879-018-3246-y","article-title":"Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment","volume":"18","author":"Kumar","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2025.107877_bib0044","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.7150\/thno.99038","article-title":"Spatial transcriptomic sequencing reveals immune microenvironment features of Mycobacterium tuberculosis granulomas in lung and omentum","volume":"14","author":"Qiu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ijid.2025.107877_bib0045","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1038\/s41467-023-44152-8","article-title":"Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy","volume":"14","author":"Gress","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2025.107877_bib0046","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163101","article-title":"Inhibition of indoleamine dioxygenase leads to better control of tuberculosis adjunctive to chemotherapy","volume":"8","author":"Singh","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.ijid.2025.107877_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1411827","article-title":"Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis","volume":"15","author":"Najafi-Fard","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2025.107877_bib0048","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3390\/jcm8122219","article-title":"Type 2 diabetes mellitus and altered immune system leading to susceptibility to pathogens, especially Mycobacterium tuberculosis","volume":"8","author":"Ferlita","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijid.2025.107877_bib0049","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/ars.2020.8124","article-title":"The interplay between systemic inflammation, oxidative stress, and tissue remodeling in tuberculosis","volume":"34","author":"Amaral","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ijid.2025.107877_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2024.152787","article-title":"Hyperglycemia modulates M1\/M2 macrophage polarization in chronic diabetic patients with pulmonary tuberculosis infection","volume":"229","author":"Panda","year":"2024","journal-title":"Immunobiology"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225001006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225001006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:41:28Z","timestamp":1770205288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225001006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"alternative-id":["S1201971225001006"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107877","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host-directed therapy in diabetes and tuberculosis comorbidity toward global tuberculosis elimination","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107877"}}